| Code | 1420A | ||||||||||
| MA number | 26/0114/05-S | ||||||||||
| Product Form: | tbl 8x250 mg (blis.PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 26 - ANTIMYCOTICA (LOKÁLNE A CELKOVÉ) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 24.05.2005 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Terbinafin Mylan 250 mg_05.2021.pdf
|
| PIL: |
PIL_Terbinafin Mylan 250 mg_01.2022.pdf
|
| Safety feature | Yes |
| Data update: | 06.09.2018 |
